Researchers will collect and analyze lung tissue from dogs enrolled in a clinical trial for bone cancer that has spread to the lungs in hopes of discovering new ways to treat this common and aggressive canine cancer.
Researchers will use a novel approach to differentiate between cancerous and normal cells surrounding splenic hemangiosarcoma tumors to improve successful tumor removal and drug delivery.
Researchers will explore the use of tiny particles called extracellular vesicles to deliver chemotherapy drugs directly to hemangiosarcoma cancer cells to pave the way for the development of much-needed new treatments.
Researchers will search for new therapy targets for hemangiosarcoma in dogs to inform the development of much-needed therapies and preventives for this deadly cancer.